Oral N-acetylcysteine administration does not stabilise the process of established severe preeclampsia.

@article{Roes2006OralNA,
  title={Oral N-acetylcysteine administration does not stabilise the process of established severe preeclampsia.},
  author={Eva Maria Roes and Maarten T. M. Raijmakers and Theo M de Boo and Petra L M Zusterzeel and Hans M W M Merkus and Wilbert H. M. Peters and Eric A P Steegers},
  journal={European journal of obstetrics, gynecology, and reproductive biology},
  year={2006},
  volume={127 1},
  pages={61-7}
}
OBJECTIVE To stabilise the disease process in women with early onset severe preeclampsia and/or HELLP syndrome by enhancing maternal antioxidants effects of glutathione. STUDY DESIGN In a randomised, double-blind, placebo-controlled trial, women with severe preeclampsia and/or HELLP syndrome received oral N-acetylcysteine. Primary outcome measures were disease stabilisation expressed as treatment-to-delivery interval and biochemical assessment of glutathione and parameters of oxidative stress… CONTINUE READING